PRKCZ, a member of the PKC family, acts as a tumor suppressor by inhibiting the NF-κB signaling pathway; its dysregulation contributes to uncontrolled cell growth and resistance to apoptosis, thereby adversely affecting patient survival when underexpressed [25]. This evidence concerns the gene PRRT2 and neoplasm.